Melanoma
Immunotherapeutic Antisense Agent Extends Survival
Published in Gene Therapy Weekly, April 12th, 2001
The company's lead investigator, Dr. Burkhard Jansen from the University of Vienna, Austria, presented the data at an educational session entitled "Apoptosis in drug development and therapy," which reviewed innovative approaches to triggering cancer cell death.
In his presentation, Jansen reviewed the clinical results on his pilot series of patients, who were treated with Genasense plus a standard drug known as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2001-04-12)
More Articles from Gene Therapy Weekly
- Gene Delivery
Pseudotyped Retrovirus Permits More Stable Transfer To More Cell Types - Hepatocellular Carcinoma
Simultaneous Adenoviral Vector Infection Induces Tissue-Specific Gene Expression - Cancer Gene Therapy
Scientists Investigate How 'Knots' In DNA Affect Genes - Glioma
Chemotherapy Response Boosted With Stereotactic Delivery Of Recombinant Retrovirus - Vector Development
Novel System For Isolation Of Full-Length Adenoviral Genomes Reported - Acute Human Myeloid Leukemia
Protein Regulates Cell Proliferation And Survival - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
